Search for: "BRISTOL-MYERS SQUIBB"
Results 1 - 20
of 889
Sorted by Relevance
|
Sort by Date
25 May 2023, 1:24 am
Jane LambertCourt of Appeal (Lord Justices Arnold, Nugee and Warby) Sandoz Ltd v Bristol-Myers Squibb Holdings Ireland Unlimited Company[2023] EWCA Civ 472 (4 May 2023)This was an appeal by Bristol Myers Squibb Ireland ("BMS") against Mr Justice Meade's judgment in Sandoz Ltd and another v Bristol-Myers Squibb Holdings Ireland (Unlimited) Company [2022] EWHC 822 (Pat) (7 April 2022)… [read post]
22 Apr 2021, 7:02 am
According to the government, Bristol-Myers Squibb underreported AMPs for a number of its drugs. [read post]
23 Jul 2009, 9:32 pm
By Sherri Oslick -- On Wednesday Bristol-Myers Squibb and Medarex, Inc. announced that they have entered into a definitive merger agreement by which Bristol-Myers Squibb will acquire Medarex for $2.4 billion. [read post]
19 Jun 2017, 12:51 pm
Today the Supreme Court issued its decision in Bristol-Myers Squibb Co. v. [read post]
19 Jun 2017, 12:51 pm
Today the Supreme Court issued its decision in Bristol-Myers Squibb Co. v. [read post]
28 Sep 2007, 12:51 pm
Article from WCVB TV/DT Boston -- Company To Pay $515M To Settle Drug Marketing Probes: Bristol-Myers Squibb Agrees To Settlement. [read post]
5 Sep 2014, 3:52 pm
Bristol-Myers Squibb Co. accused Merck & Co. of infringing a new U.S. patent for a novel method of cancer-fighting that uses a patient’s own immune system to fight the disease. [read post]
2 Apr 2019, 6:53 am
Consolidated World Travel, Inc. is the latest salvo in the conflict over whether the Supreme Court’s personal jurisdiction decision in Bristol-Myers Squibb applies in the class action context. [read post]
8 Jun 2007, 12:49 pm
In another stirring chapter of the on-going Plavix debacle, the Bristol-Myers Squibb pleaded guilty to two criminal counts of two violations of the federal False Statements Act and will pay a $1 million fine (the maximum penalty) for lying to the federal government about a patent deal involving the anticoagulant drug Plavix (clopidogrel bisulfate). [read post]
12 Apr 2021, 2:30 pm
… The post Whistleblower Reports Bristol-Myers Squibb Medicaid Drug Rebate Fraud, Resulting in $75 Million Recovery for The U.S. [read post]
2 Aug 2012, 1:20 pm
Ramnarine, an executive at Bristol-Myers Squibb, with insider trading on confidential information about companies being targeted for potential acquisitions. [read post]
2 Oct 2007, 6:53 pm
By Sherri Oslick -- Last week, Bristol-Myers Squibb Co. of Princeton, NJ announced that it would acquire biotechnology company Adnexus Therapeutics Inc. of Waltham, MA for $430 million in cash (with an additional $75 million to be paid provided Adnexus meets certain regulatory milestones). [read post]
10 Sep 2020, 10:24 am
” https://news.bms.com/news/details/2020/The-Bristol-Myers-Squibb-Pfizer-Alliance-is-pleased-with-the-U.S. [read post]
7 Sep 2010, 11:15 pm
Bristol-Myers Squibb said Tuesday it had agreed to acquire ZymoGenetics, the maker of a hepatitis C drug the companies were jointly developing, for $885 million. [read post]
19 Jan 2017, 12:06 pm
Supreme Court granted certiorari in Bristol-Myers Squibb Co. v. [read post]
29 Sep 2007, 10:48 pm
The lawsuits alleged that between 2000 and 2003, Bristol-Myers Squibb offered kickbacks to physicians and other healthcare providers to get them to promote Bristol-Myers Squibb drugs. [read post]
30 Apr 2021, 10:23 am
[…] The post Bristol-Myers Squibb Pays $75 Million to settle False Claims Act case on underpayment of drug rebates owed through medicaid appeared first on Newman & Shapiro. [read post]
15 Feb 2016, 5:56 am
According to a recent news feature from Fierce Pharma, Bristol-Myers Squibb (BMY) has reported huge profits over the past fiscal quarter. [read post]
7 Dec 2009, 4:04 am
Bristol-Myers Squibb, winner of a 2009 Employers of Choice commendation from Diversity & the Bar, Vol. 11, Nov. [read post]
12 Jun 2017, 7:09 am
Reuters reports that Bristol-Myers Squibb has agreed to pay $19.5 million to 43 states and the District of Columbia to settle accusations “that it improperly promoted” Abilify (aripiprazole) “for use in children and elderly patients with dementia and Alzheimer’s disease. [read post]
